SNRPGP13

Across TCGA pan-cancer cohorts, SNRPGP13 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated SNRPGP13 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher SNRPGP13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNRPGP13 expression acts as an unfavorable survival marker.

READ, KIRP, and STAD are the cancer types where SNRPGP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	IV	0.111	0.893	<.001	72	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	60	view →
STAD	DFS	Tertile	II,III,IV	0.433	0.578	.007	52	view →
THCA	DFS	Tertile	II,III,IV	0.237	0.779	.016	21	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	18	view →
LGG	DFS	Tertile	All	0.132	0.826	<.001	18	view →
LUSC	DFS	Tertile	II,III,IV	0.536	0.789	.022	12	view →
LAML	DFS	Median	All	0.224	0.486	.022	8	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

SNRPGP13–READ (OS)

Open the READ breakdown →